BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28112737)

  • 1. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
    de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
    Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
    Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
    Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
    Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
    de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
    Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
    de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
    Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
    Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
    Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
    Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
    Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
    Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution.
    Su N; Li Z; Yang J; Fu Y; Zhu X; Miao H; Yu Y; Jiang W; Le J; Qian X; Wang H; Qian M; Zhai X
    Front Oncol; 2022; 12():915833. PubMed ID: 36003795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
    Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.
    Cardin S; Bilodeau M; Roussy M; Aubert L; Milan T; Jouan L; Rouette A; Laramée L; Gendron P; Duchaine J; Decaluwe H; Spinella JF; Mourad S; Couture F; Sinnett D; Haddad É; Landry JR; Ma J; Humphries RK; Roux PP; Hébert J; Gruber TA; Wilhelm BT; Cellot S
    Blood Adv; 2019 Nov; 3(21):3307-3321. PubMed ID: 31698461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of pediatric acute megakaryoblastic leukemia.
    Gruber TA; Downing JR
    Blood; 2015 Aug; 126(8):943-9. PubMed ID: 26186939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome.
    Nikolaev SI; Santoni F; Vannier A; Falconnet E; Giarin E; Basso G; Hoischen A; Veltman JA; Groet J; Nizetic D; Antonarakis SE
    Blood; 2013 Jul; 122(4):554-61. PubMed ID: 23733339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular lesions in childhood and adult acute megakaryoblastic leukaemia.
    Hama A; Muramatsu H; Makishima H; Sugimoto Y; Szpurka H; Jasek M; O'Keefe C; Takahashi Y; Sakaguchi H; Doisaki S; Shimada A; Watanabe N; Kato K; Kiyoi H; Naoe T; Kojima S; Maciejewski JP
    Br J Haematol; 2012 Feb; 156(3):316-25. PubMed ID: 22122069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
    Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
    J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.
    Ishibashi M; Yokosuka T; Yanagimachi MD; Iwasaki F; Tsujimoto SI; Sasaki K; Takeuchi M; Tanoshima R; Kato H; Kajiwara R; Tanaka F; Goto H; Yokota S
    Turk J Haematol; 2016 Dec; 33(4):331-334. PubMed ID: 27094503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of somatic mutations in Down syndrome-related myeloid disorders.
    Yoshida K; Toki T; Okuno Y; Kanezaki R; Shiraishi Y; Sato-Otsubo A; Sanada M; Park MJ; Terui K; Suzuki H; Kon A; Nagata Y; Sato Y; Wang R; Shiba N; Chiba K; Tanaka H; Hama A; Muramatsu H; Hasegawa D; Nakamura K; Kanegane H; Tsukamoto K; Adachi S; Kawakami K; Kato K; Nishimura R; Izraeli S; Hayashi Y; Miyano S; Kojima S; Ito E; Ogawa S
    Nat Genet; 2013 Nov; 45(11):1293-9. PubMed ID: 24056718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
    Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
    J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.
    Gruber TA; Larson Gedman A; Zhang J; Koss CS; Marada S; Ta HQ; Chen SC; Su X; Ogden SK; Dang J; Wu G; Gupta V; Andersson AK; Pounds S; Shi L; Easton J; Barbato MI; Mulder HL; Manne J; Wang J; Rusch M; Ranade S; Ganti R; Parker M; Ma J; Radtke I; Ding L; Cazzaniga G; Biondi A; Kornblau SM; Ravandi F; Kantarjian H; Nimer SD; Döhner K; Döhner H; Ley TJ; Ballerini P; Shurtleff S; Tomizawa D; Adachi S; Hayashi Y; Tawa A; Shih LY; Liang DC; Rubnitz JE; Pui CH; Mardis ER; Wilson RK; Downing JR
    Cancer Cell; 2012 Nov; 22(5):683-97. PubMed ID: 23153540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.